Tandem Diabetes Care, Inc.

TNDM: Is Tandem Diabetes Care, Inc. Halal?

Tandem Diabetes Care, Inc.

NASDAQHealthcareUS

$15.41

+0.26%

Market Cap: 1.1B

Compliance Status

Doubtful

Screened on Jul 20, 2026 · AAOIFI Standard 21

C

Marginal

48Score

Is Tandem Diabetes Care, Inc. (TNDM) halal? Doubtful. Based on AAOIFI screening, Tandem Diabetes Care, Inc. passes the business activity screen but has financial ratios approaching AAOIFI limits with a compliance score of 48/100 (Grade: C).

Business activity

What the company sells is permissible.

Passed

Company debt

Close to the limit

How much the company borrows, compared to its total value. AAOIFI allows up to 30%.

29.4% of 30.0% limit

What this means for you

You may own TNDM, with caution

Its numbers sit close to AAOIFI limits. Cautious investors may prefer alternatives or ask a scholar first.

Purify 1% of your income from TNDM

That is about $1.00 of every $100 you earn from it. Donate this share to charity.

Calculate my exact amount

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc., a medical technology firm, specializes in creating, developing, and marketing solutions for individuals globally who manage insulin-dependent diabetes. At the core of its offerings is the t:slim X2 insulin delivery system, an advanced pump platform that integrates the t:slim X2 pump, a disposable 300-unit insulin cartridge, and an infusion set. Tandem further enhances this platform with innovative features like Basal-IQ and Control-IQ technology, as well as G5 Integration capabilities. The company also provides the Tandem Device Updater, enabling users to easily update their pump's software. To facilitate therapy management, Tandem offers t:connect, a web-based application that visually presents diabetes data from the pump, continuous glucose monitoring (CGM) devices, and supported blood glucose meters to patients, their caregivers, and healthcare professionals. Additionally, the Sugarmate mobile application caters specifically to insulin users with diabetes. Tandem has strategic development and commercialization partnerships with leading companies such as Dexcom, Inc. and Abbott Laboratories. Established in 2006 and headquartered in San Diego, California, the company was initially known as Phluid Inc. before rebranding as Tandem Diabetes Care, Inc. in January 2008.

Sector: Healthcare · Industry: Medical - Devices

Why This Stock Is Doubtful

  • Debt is 29.4% of market cap, only 0.6 points below the 30% AAOIFI limit
  • Interest-bearing deposits are 27.7% of market cap, only 2.3 points below the 30% limit

Stocks are marked Doubtful when financial ratios pass but approach AAOIFI thresholds. Consider consulting a qualified scholar for a definitive ruling.

Shariah Compliance Status

AAOIFI Standard 21Updated Jul 20, 2026

Compliance History

  1. Doubtfulnow

    since Jun 2026

  2. Halal

    until the change above

  3. Doubtful

    until the change above

Tracked since May 2026. Updates automatically on each re-screen.

Fiscal: Q1 2026Data source: EDGAR
Free · No credit card required

Track TNDM and 10,000+ stocks with AI insights

Create your free account to unlock AI-powered compliance analysis, track your portfolio, calculate purification, and get unlimited AAOIFI screening.

10,000+ assets AAOIFI standards Free watchlist

Frequently Asked Questions

Is Tandem Diabetes Care, Inc. (TNDM) halal to invest in?
Tandem Diabetes Care, Inc. (TNDM) is rated Doubtful under AAOIFI Standard 21. It passes the business activity screen but one or more financial ratios are approaching (though not yet exceeding) the AAOIFI thresholds (30% for debt and interest deposits, 5% for prohibited income). Consult a qualified Islamic finance scholar for a personal ruling.
Why did Tandem Diabetes Care, Inc. get a C compliance rating?
Tandem Diabetes Care, Inc. (TNDM) received a grade of C (Marginal) based on three AAOIFI Standard 21 financial ratios: debt-to-market-cap of 29.4% (limit 30%); interest-bearing deposits of 27.7% (limit 30%); prohibited income of 0.97% (limit 5%). The grade reflects the margin of safety across all three ratios relative to their thresholds.
What could change Tandem Diabetes Care, Inc.'s Shariah verdict?
Tandem Diabetes Care, Inc.'s verdict is re-evaluated at each annual re-screen. Three events could change it: (1) the debt-to-market-cap ratio crossing 30%, typically from new debt issuance or a major drop in share price; (2) interest-bearing deposits exceeding 30% of market cap; or (3) prohibited revenue (alcohol, gambling, conventional finance, etc.) exceeding 5% of total revenue. Verdict flips are tracked in the compliance history section above.
How often is Tandem Diabetes Care, Inc. re-screened for Shariah compliance?
Tandem Diabetes Care, Inc. (TNDM) is re-screened annually using the most recent full-year financial data from SEC filings. HalalScreener also triggers an on-demand re-screen whenever the stored data is more than 7 days old, ensuring the ratios reflect the latest available financial statements. Last screened: Jul 20, 2026.

Screened according to AAOIFI Standard No. 21 · For informational purposes only. Consult a qualified Islamic finance advisor before investing.

Disclaimer: This screening is for informational purposes only and does not constitute financial, legal, or religious advice. Compliance is evaluated using AAOIFI financial standards (debt, deposits, and prohibited income ratios) and publicly available data. Ethical, political, social, or environmental considerations are outside the scope of this screening. Individual scholars and methodologies may differ. Always consult a qualified Islamic finance advisor before making investment decisions.